http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102464594-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_500def13140adc2c5ff96ea7ee683045
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C255-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C255-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C253-30
filingDate 2010-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4af7be24613850a5cf7f058000cb6b0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c3128456164f1d5a187a2d3b9b60416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa58dd817f592dcd87f4927705480b4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28aff665704d6f617a65d822281d49dd
publicationDate 2012-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102464594-A
titleOfInvention The preparation method of the intermediate compound of pregabalin
abstract The invention discloses a preparation method of an intermediate compound II of pregabalin, which comprises the following steps: (1) subjecting compound VI and XCH 2 COOR 2 to SN 2 substitution reaction to obtain compound I; (2) combining Wittig-Hornor reaction of compound I obtained in step (1) with isobutyraldehyde; wherein, R 1 is a C 1 -C 6 alkoxy group or a C 6 -C 10 aryl group, X is a halogen, and R 2 is a C 1 -C 6 alkyl group. The present invention also relates to a preparation method for intermediate compound V of pregabalin, which comprises the following steps: in a solvent, under the action of catalyst [Rh((Sc, Rp)-Duanpos)(COD)] BF 4 , Compound IV and hydrogen can be subjected to asymmetric hydrogenation reaction; wherein, M is H, C 1 -C 6 alkyl or t-BuNH 3 + .
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105348126-A
priorityDate 2010-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008095678-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID125889
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466370221
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556589
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9898885
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426408651
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467325166

Total number of triples: 23.